A detailed history of Granite Group Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Granite Group Advisors, LLC holds 6,677 shares of AMGN stock, worth $2.12 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares
6,677
Previous 6,509 2.58%
Holding current value
$2.12 Million
Previous $2.03 Billion 5.79%
% of portfolio
1.38%
Previous 1.54%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$309.38 - $337.38 $51,975 - $56,679
168 Added 2.58%
6,677 $2.15 Billion
Q2 2024

Jul 23, 2024

BUY
$262.75 - $319.31 $195,486 - $237,566
744 Added 12.91%
6,509 $2.03 Billion
Q1 2024

May 31, 2024

BUY
$268.87 - $324.56 $74,208 - $89,578
276 Added 5.03%
5,765 $1.64 Billion
Q4 2023

Apr 03, 2024

BUY
$255.7 - $288.46 $1.4 Million - $1.58 Million
5,489 New
5,489 $1.51 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $170B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Granite Group Advisors, LLC Portfolio

Follow Granite Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Group Advisors, LLC with notifications on news.